Status:
RECRUITING
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Eye Diseases
Visual Impairment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of bli...
Eligibility Criteria
Inclusion
- • Speak English, Spanish, Arabic, Chinese, French, Hindi, Finnish, Albanian, Russian or Tagalog
Exclusion
- significant eye pain
- sudden decrease in vision within one week
- binocular diplopia
- cognitive impairment
- pregnancy
- previously declined participation
Key Trial Info
Start Date :
December 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2030
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT06934577
Start Date
December 4 2025
End Date
August 1 2030
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Optometry Clinic
Flint, Michigan, United States, 48505.